Clinical Trials
3 trialsNCT03875157 2023-02-27
Study of IBI318 in Participants With Advanced Malignancies
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Completed
NCT02978482 2021-08-18
A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced Malignancies
AstraZeneca
Phase 1 Completed
NCT04216082 2020-01-02
A Study of Anlotinib in Subjects With Advanced Malignancy
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2 Completed